Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Eil

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Surgery|November 26, 2022
Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysisThomas L Sutton, Liam H Wong, Brett S Walker, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Pancreatic cancer cells overexpressing interleukin 6 induce T-cell-mediated tumor clearance and durable anti-tumor immune responsePaige C Arneson-Wissink, Alexandra Q Bartlett, Heike Mendez, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 7, 2023
Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic InnovationsRanish K Patel, Shahrose Rahman, Issac R Schwantes, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinomaYifei Guo, Jennifer M Finan, Alexandra Q Bartlett, et al.
Nature Communications|December 24, 2016
Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis inductionAnthony C Cruz, Madhu Ramaswamy, Claudia Ouyang, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 18, 2026
Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancerPaige C Arneson-Wissink, Alexandra Q Bartlett, Heike Mendez, et al.
The Journal of Experimental Medicine|June 10, 2020
BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppressionFrancis M Grant, Jie Yang, Rabab Nasrallah, et al.
Cancer Cell|June 10, 2020
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesDevikala Gurusamy, Amanda N Henning, Tori N Yamamoto, et al.
Nature|September 15, 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector functionRobert Eil, Suman K Vodnala, David Clever, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Surgery|November 26, 2022
Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysisThomas L Sutton, Liam H Wong, Brett S Walker, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Pancreatic cancer cells overexpressing interleukin 6 induce T-cell-mediated tumor clearance and durable anti-tumor immune responsePaige C Arneson-Wissink, Alexandra Q Bartlett, Heike Mendez, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 7, 2023
Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic InnovationsRanish K Patel, Shahrose Rahman, Issac R Schwantes, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinomaYifei Guo, Jennifer M Finan, Alexandra Q Bartlett, et al.
Nature Communications|December 24, 2016
Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis inductionAnthony C Cruz, Madhu Ramaswamy, Claudia Ouyang, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 18, 2026
Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancerPaige C Arneson-Wissink, Alexandra Q Bartlett, Heike Mendez, et al.
The Journal of Experimental Medicine|June 10, 2020
BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppressionFrancis M Grant, Jie Yang, Rabab Nasrallah, et al.
Cancer Cell|June 10, 2020
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesDevikala Gurusamy, Amanda N Henning, Tori N Yamamoto, et al.
Nature|September 15, 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector functionRobert Eil, Suman K Vodnala, David Clever, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Pageof 3